We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Ensign Group Expands Foothold in Three U.S. States With Facility Buyouts
Read MoreHide Full Article
Key Takeaways
ENSG acquired operations of four skilled nursing facilities effective Dec. 1, 2025.
The new facilities expand ENSG's reach in Colorado, Arizona and Kansas markets.
ENSG now operates 373 healthcare facilities across 17 states, including 47 senior living sites.
The Ensign Group, Inc. (ENSG - Free Report) recently acquired operations of four skilled nursing facilities effective Dec. 1, 2025. These include The Rehabilitation Center at Sandalwood, Edgewater Health and Rehabilitation, Willow Point Rehabilitation and Nursing Center and Santa Rosa Care Center. The first two facilities are located in Colorado and are equipped with 103 and 69 beds, respectively. The third facility comprises 45 beds and is situated in Kansas, while the fourth one is located in Arizona and equipped with 144 beds.
These facilities are operated under long-term, triple net leases with third-party landlords, while the Kansas facility’s real estate was purchased by Standard Bearer Healthcare REIT, Ensign’s captive real estate arm.
By collaborating closely with dedicated caregiver teams at its newly acquired facilities, ENSG will deepen its understanding of the unique needs of local communities, enabling it to deliver enhanced, patient-centered care to residents and their families.
The transactions have taken the count of Ensign Group’s portfolio to a total of 373 healthcare operations, including 47 senior living facilities, spread across 17 states. Additionally, Ensign Group’s subsidiaries—such as Standard Bearer Healthcare REIT—presently own 156 real estate assets.
Benefits Reaped by Ensign Group Out of Such Expansion Initiatives
Apart from a growing healthcare portfolio, the recent facility buyouts are expected to strengthen ENSG’s presence across Colorado, Arizona and Kansas.
The year 2025 so far has been quite active for the company on the acquisition front. Some other states in which Ensign Group has undertaken similar moves so far in 2025 remain those of Utah, Alabama, Wisconsin, Iowa, to name a few. This consistent pace of strategic growth has greatly bolstered its expansion into various communities across the United States, reinforcing its national footprint. These efforts have played a key role in bridging care gaps and delivering essential support to underserved populations in need of quality healthcare services.
The addition of more skilled nursing facilities, such as those in the recent acquisition, enables the healthcare provider to reach a wider patient base, potentially driving robust revenue growth within its Skilled Services segment. This segment has traditionally been a key revenue driver for ENSG, contributing 96% of total revenues during the first nine months of 2025. Furthermore, the acquisition of the Kansas-based facility is expected to enhance rental income generated through Ensign Group’s real estate arm, Standard Bearer.
ENSG’s Share Price Performance & Zacks Rank
Shares of Ensign Group have gained 24.4% in the past year compared with the industry’s 22.7% growth. ENSG currently carries a Zacks Rank #2 (Buy).
Collegium Pharmaceutical’s earnings surpassed estimates in each of the last four quarters, the average surprise being 10.63%. The Zacks Consensus Estimate for COLL’s 2025 earnings indicates a rise of 17.1% from the 2024 figure. The consensus mark for revenues implies an improvement of 24.2% from the 2024 figure. The consensus mark for COLL’s 2025 earnings has moved 6.6% north in the past 30 days.
The bottom line of ANI Pharmaceuticals outpaced estimates in each of the trailing four quarters, the average surprise being 21.24%. The Zacks Consensus Estimate for ANIP’s 2025 earnings indicates a rise of 45% from the 2024 figure. The consensus mark for revenues implies an improvement of 41.6% from the 2024 figure. The consensus mark for ANIP’s 2025 earnings has moved 3.4% north in the past 30 days.
Intuitive Surgical’s earnings surpassed estimates in each of the last four quarters, the average surprise being 16.34%. The Zacks Consensus Estimate for ISRG’s 2025 earnings indicates a rise of 17.3% from the 2024 figure. The consensus mark for revenues implies an improvement of 18.7% from the 2024 figure. The consensus mark for ISRG’s 2025 earnings has moved 5.5% north in the past 60 days.
Shares of Collegium Pharmaceutical, ANI Pharmaceuticals and Intuitive Surgical have gained 53.7%, 44.7% and 2.7%, respectively, in the past year.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Shutterstock
Ensign Group Expands Foothold in Three U.S. States With Facility Buyouts
Key Takeaways
The Ensign Group, Inc. (ENSG - Free Report) recently acquired operations of four skilled nursing facilities effective Dec. 1, 2025. These include The Rehabilitation Center at Sandalwood, Edgewater Health and Rehabilitation, Willow Point Rehabilitation and Nursing Center and Santa Rosa Care Center. The first two facilities are located in Colorado and are equipped with 103 and 69 beds, respectively. The third facility comprises 45 beds and is situated in Kansas, while the fourth one is located in Arizona and equipped with 144 beds.
These facilities are operated under long-term, triple net leases with third-party landlords, while the Kansas facility’s real estate was purchased by Standard Bearer Healthcare REIT, Ensign’s captive real estate arm.
By collaborating closely with dedicated caregiver teams at its newly acquired facilities, ENSG will deepen its understanding of the unique needs of local communities, enabling it to deliver enhanced, patient-centered care to residents and their families.
The transactions have taken the count of Ensign Group’s portfolio to a total of 373 healthcare operations, including 47 senior living facilities, spread across 17 states. Additionally, Ensign Group’s subsidiaries—such as Standard Bearer Healthcare REIT—presently own 156 real estate assets.
Benefits Reaped by Ensign Group Out of Such Expansion Initiatives
Apart from a growing healthcare portfolio, the recent facility buyouts are expected to strengthen ENSG’s presence across Colorado, Arizona and Kansas.
The year 2025 so far has been quite active for the company on the acquisition front. Some other states in which Ensign Group has undertaken similar moves so far in 2025 remain those of Utah, Alabama, Wisconsin, Iowa, to name a few. This consistent pace of strategic growth has greatly bolstered its expansion into various communities across the United States, reinforcing its national footprint. These efforts have played a key role in bridging care gaps and delivering essential support to underserved populations in need of quality healthcare services.
The addition of more skilled nursing facilities, such as those in the recent acquisition, enables the healthcare provider to reach a wider patient base, potentially driving robust revenue growth within its Skilled Services segment. This segment has traditionally been a key revenue driver for ENSG, contributing 96% of total revenues during the first nine months of 2025. Furthermore, the acquisition of the Kansas-based facility is expected to enhance rental income generated through Ensign Group’s real estate arm, Standard Bearer.
ENSG’s Share Price Performance & Zacks Rank
Shares of Ensign Group have gained 24.4% in the past year compared with the industry’s 22.7% growth. ENSG currently carries a Zacks Rank #2 (Buy).
Image Source: Zacks Investment Research
Other Stocks to Consider
Some other top-ranked stocks in the Medical space are Collegium Pharmaceutical, Inc. (COLL - Free Report) , ANI Pharmaceuticals, Inc. (ANIP - Free Report) and Intuitive Surgical, Inc. (ISRG - Free Report) , each currently sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Collegium Pharmaceutical’s earnings surpassed estimates in each of the last four quarters, the average surprise being 10.63%. The Zacks Consensus Estimate for COLL’s 2025 earnings indicates a rise of 17.1% from the 2024 figure. The consensus mark for revenues implies an improvement of 24.2% from the 2024 figure. The consensus mark for COLL’s 2025 earnings has moved 6.6% north in the past 30 days.
The bottom line of ANI Pharmaceuticals outpaced estimates in each of the trailing four quarters, the average surprise being 21.24%. The Zacks Consensus Estimate for ANIP’s 2025 earnings indicates a rise of 45% from the 2024 figure. The consensus mark for revenues implies an improvement of 41.6% from the 2024 figure. The consensus mark for ANIP’s 2025 earnings has moved 3.4% north in the past 30 days.
Intuitive Surgical’s earnings surpassed estimates in each of the last four quarters, the average surprise being 16.34%. The Zacks Consensus Estimate for ISRG’s 2025 earnings indicates a rise of 17.3% from the 2024 figure. The consensus mark for revenues implies an improvement of 18.7% from the 2024 figure. The consensus mark for ISRG’s 2025 earnings has moved 5.5% north in the past 60 days.
Shares of Collegium Pharmaceutical, ANI Pharmaceuticals and Intuitive Surgical have gained 53.7%, 44.7% and 2.7%, respectively, in the past year.